G V Sharma, G Cella, A F Parisi, A A Sasahara. Show Affiliations »
Abstract
Mesh: See more » Arterial Occlusive Diseases/drug therapyBlood Coagulation TestsChronic DiseaseClinical Trials as TopicCoronary Disease/drug therapyCoronary VesselsFibrinolytic Agents/adverse effectsFibrinolytic Agents/therapeutic useHumansInfusions, ParenteralMicrocirculationMyocardial Infarction/drug therapyPulmonary CirculationPulmonary Embolism/drug therapyStreptokinase/administration & dosageStreptokinase/therapeutic useThromboembolism/drug therapyThrombophlebitis/drug therapyUrokinase-Type Plasminogen Activator/administration & dosageUrokinase-Type Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsStreptokinaseUrokinase-Type Plasminogen Activator
Year: 1982 PMID: 7040966 DOI: 10.1056/NEJM198205273062105
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245